
Epalrestat
In vial of 0.5 g net
TargetMol Chemicals Inc.
Product Overview
Product / Grade Name
Epalrestat
Maker Name
Product Description
Epalrestat (ONO2235), an aldose reductase inhibitor, is well tolerated in Long-term therapy. It can effectually ameliorate the associated symptoms of diabetic neuropathy and delay the progression of the disease, particularly in patients with limited microangiopathy and good glycemic control.
Hazard Classification
UN Number
:IMGD Class
:Packing Group
:
Visual Overview
Corporate Video
